Webb et al., 2020 - Google Patents
Protein arginine methyltransferase 5 promotes cholesterol biosynthesis–mediated Th17 responses and autoimmunityWebb et al., 2020
View HTML- Document ID
- 7990791805824183403
- Author
- Webb L
- Sengupta S
- Edell C
- Piedra-Quintero Z
- Amici S
- Miranda J
- Bevins M
- Kennemer A
- Laliotis G
- Tsichlis P
- Guerau-de-Arellano M
- et al.
- Publication year
- Publication venue
- The Journal of clinical investigation
External Links
Snippet
Protein arginine methyltransferase 5 (PRMT5) catalyzes symmetric dimethylation (SDM) of arginine, a posttranslational modification involved in oncogenesis and embryonic development. However, the role and mechanisms by which PRMT5 modulates Th cell …
- 101710039833 PRMT5 0 title abstract description 224
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Webb et al. | Protein arginine methyltransferase 5 promotes cholesterol biosynthesis–mediated Th17 responses and autoimmunity | |
Anandagoda et al. | microRNA-142–mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance | |
Itoh et al. | The X-linked histone demethylase Kdm6a in CD4+ T lymphocytes modulates autoimmunity | |
Dhillon et al. | The nuclear receptor ESRRA protects from kidney disease by coupling metabolism and differentiation | |
Waddell et al. | Dlk1 is necessary for proper skeletal muscle development and regeneration | |
Li et al. | c-Rel is a myeloid checkpoint for cancer immunotherapy | |
Gu et al. | Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia | |
Syrett et al. | Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells | |
Cao et al. | The xenobiotic transporter Mdr1 enforces T cell homeostasis in the presence of intestinal bile acids | |
Mishra et al. | The histone methyltransferase activity of MLL1 is dispensable for hematopoiesis and leukemogenesis | |
Kim et al. | Selenoprotein W ensures physiological bone remodeling by preventing hyperactivity of osteoclasts | |
Hiller et al. | Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity | |
Mani et al. | Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer | |
Burton et al. | Cellular senescence: from growth arrest to immunogenic conversion | |
Liu et al. | MiR-17 modulates osteogenic differentiation through a coherent feed-forward loop in mesenchymal stem cells isolated from periodontal ligaments of patients with periodontitis | |
Polansky et al. | Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells | |
Chevrier et al. | IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation | |
Liu et al. | Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA | |
Sanctuary et al. | miR-106a deficiency attenuates inflammation in murine IBD models | |
Huang et al. | mir-500-Mediated GAD67 downregulation contributes to neuropathic pain | |
Mazzola et al. | Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation | |
Rashkovan et al. | Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V (D) J recombination | |
Markegard et al. | Basal LAT-diacylglycerol-RasGRP1 signals in T cells maintain TCRα gene expression | |
Kadota et al. | Srsf7 establishes the juvenile transcriptome through age-dependent alternative splicing in mice | |
Hewitson et al. | miR‐132 suppresses transcription of ribosomal proteins to promote protective Th1 immunity |